Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
UpcomingCenters for Disease Control and Prevention - ERA · Opportunity number RFA-TS-27-018 · Forecast
Closing date explanation: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Eligibility
Nonprofits are listed as eligible applicants.
- Public and state controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- State governments
- City or township governments
- County governments
- Independent school districts
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Special district governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Eligibility Information to be included in the NOFO.
Description
CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.
Funding
| Total program funding | $4,500,000 |
|---|---|
| Award floor | Not listed |
| Award ceiling | $500,000 |
| Category | Health |
| Assistance listing | 93.061 |
Official sources
Last verified on Grants.gov Nov 4, 2026. Grantvello is not affiliated with Grants.gov or Centers for Disease Control and Prevention - ERA. The notice on Grants.gov is the binding text.